Common Stock, Shares, Issued of Alzamend Neuro, Inc. from Q1 2020 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Alzamend Neuro, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q1 2020 to Q2 2025.
  • Alzamend Neuro, Inc. Common Stock, Shares, Issued for the quarter ending July 31, 2025 was 3.14M shares, a 265% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Alzamend Neuro, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 3.14M +2.28M +265% Jul 31, 2025 10-Q 2025-09-10
Q1 2025 779K +702K +919% Apr 30, 2025 10-Q 2025-09-10
Q4 2024 5.8M -822K -12.4% Jan 31, 2025 10-Q 2025-03-10
Q3 2024 5.23M -1.24M -19.1% Oct 31, 2024 10-Q 2024-12-11
Q2 2024 861K -96.1M -99.1% Jul 31, 2024 10-Q 2024-09-11
Q1 2024 76.4K -570K -88.2% Apr 30, 2024 10-K 2025-07-22
Q4 2023 6.62M -89.8M -93.1% Jan 31, 2024 10-Q 2024-03-25
Q3 2023 6.47M -89M -93.2% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 96.9M +1.46M +1.53% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 646K -94.8M -99.3% Apr 30, 2023 10-K 2024-07-30
Q4 2022 96.4M +6.33M +7.02% Jan 31, 2023 10-Q 2023-03-15
Q3 2022 95.5M +6.64M +7.48% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 95.5M Jul 31, 2022 10-Q 2022-09-13
Q1 2022 95.5M +28.1M +41.6% Apr 30, 2022 10-K 2023-07-27
Q4 2021 90.1M Jan 31, 2022 10-Q 2022-03-15
Q3 2021 88.9M Oct 31, 2021 10-Q 2021-12-13
Q1 2021 67.4M +2.67M +4.12% Apr 30, 2021 10-K 2022-07-19
Q1 2020 64.8M Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.